These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30052313)

  • 1. ST2 and B-type natriuretic peptide kinetics during exercise in severe heart failure.
    Magini A; Farina S; Riggio D; Sandri MT; Agostoni P
    Eur J Heart Fail; 2018 Oct; 20(10):1494-1495. PubMed ID: 30052313
    [No Abstract]   [Full Text] [Related]  

  • 2. [From BNP to ST2: Which biomarkers to use in practice?].
    Logeart D; Baudet M
    Presse Med; 2016 Oct; 45(10):877-884. PubMed ID: 27387365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble ST2 and brain natriuretic peptide predict different mode of death in patients with heart failure and preserved ejection fraction.
    Sugano A; Seo Y; Ishizu T; Sai S; Yamamoto M; Hamada-Harimura Y; Machino-Ohtsuka T; Obara K; Nishi I; Aonuma K; Nogami A
    J Cardiol; 2019 Apr; 73(4):326-332. PubMed ID: 30580891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine.
    Wettersten N; Maisel AS
    Am J Med; 2016 Jun; 129(6):560-7. PubMed ID: 26844635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can adiponectin be a novel metabolic biomarker for heart failure?
    Okamoto H
    Circ J; 2009 Jun; 73(6):1012-3. PubMed ID: 19465781
    [No Abstract]   [Full Text] [Related]  

  • 6. The real-life value of ST2 monitoring during heart failure decompensation: impact on long-term readmission and mortality.
    Llibre C; Zamora E; Caballero À; Lupón J; Ros A; Benito N; de Antonio M; Galán A; Domingo M; Bayes-Genis A
    Biomarkers; 2016; 21(3):225-32. PubMed ID: 26767401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Heart Failure Biomarkers Predict Improvement of Mitral Regurgitation in Patients Receiving Cardiac Resynchronization Therapy-The BIOCRT Study.
    Beaudoin J; Singh JP; Szymonifka J; Zhou Q; Levine RA; Januzzi JL; Truong QA
    Can J Cardiol; 2016 Dec; 32(12):1478-1484. PubMed ID: 27527259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for efficient diagnostic and prognostic biomarkers of heart failure.
    Emdin M; Mirizzi G; Pastormerlo LE; Poletti R; Giannelli E; Prontera C; Passino C; Vergaro G
    Future Cardiol; 2016 May; 12(3):327-37. PubMed ID: 27092725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population.
    Parikh RH; Seliger SL; Christenson R; Gottdiener JS; Psaty BM; deFilippi CR
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diabetes on the predictive value of heart failure biomarkers.
    Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
    Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTproBNP and ST2 as predictors for all-cause and cardiovascular mortality in elderly patients with symptoms suggestive for heart failure.
    Boman K; Thormark Fröst F; Bergman AR; Olofsson M
    Biomarkers; 2018; 23(4):373-379. PubMed ID: 29355441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum carbohydrate antigen 125 levels in advanced heart failure: relation to B-type natriuretic peptide and left atrial volume.
    Duman D; Palit F; Simsek E; Bilgehan K
    Eur J Heart Fail; 2008 Jun; 10(6):556-9. PubMed ID: 18501671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic Variability of Soluble ST2 in Patients With Stable Chronic Heart Failure and Implications for Monitoring.
    Piper S; deCourcey J; Sherwood R; Amin-Youssef G; McDonagh T
    Am J Cardiol; 2016 Jul; 118(1):95-8. PubMed ID: 27189812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure.
    Lim TK; Ashrafian H; Dwivedi G; Collinson PO; Senior R
    Eur J Heart Fail; 2006 Jan; 8(1):38-45. PubMed ID: 16115798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure.
    Williams SG; Ng LL; O'Brien RJ; Taylor S; Li YF; Tan LB
    Am J Cardiol; 2004 Jun; 93(12):1560-1. PubMed ID: 15194038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-Marker Strategy in Heart Failure: Combination of ST2 and CRP Predicts Poor Outcome.
    Dupuy AM; Curinier C; Kuster N; Huet F; Leclercq F; Davy JM; Cristol JP; Roubille F
    PLoS One; 2016; 11(6):e0157159. PubMed ID: 27311068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction.
    Gruson D; Lepoutre T; Ahn SA; Rousseau MF
    Int J Cardiol; 2014; 172(1):e250-2. PubMed ID: 24467978
    [No Abstract]   [Full Text] [Related]  

  • 20. Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction.
    Boulogne M; Sadoune M; Launay JM; Baudet M; Cohen-Solal A; Logeart D
    Int J Cardiol; 2017 Jan; 226():53-59. PubMed ID: 27788390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.